{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:06:01Z","timestamp":1783688761619,"version":"3.55.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Lithium is a well-known agent to cause systemic toxicity with its narrow therapeutic window. Toxic cardiac effects are known but seldomly reported and can manifest as sinus node dysfunction (SND) ranging from delayed conduction to sinus arrest with the potential to induce asystole. Theophylline a positive chronotropic agent has been previously used for correction of sinus node dysfunction but never been utilized for the correction of lithium-induced SND. We report the first successful use of Theophylline for rate\/rhythm correction of SND in a patient presenting with acute lithium toxicity along with a review summarizing the clinical features of all published literature regarding lithium-induced SND.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Case report and systematic review of the literature are presented. Three independent scientific databases were queried for reports of lithium-induced SND. A clinical compendium was then generated detailing associated clinical data and descriptive statistics were performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1,117 reports were initially retrieved with full-text review yielding a cohort of 49 unique, independent studies. (61.4%) of patients presented with a supratherapeutic lithium level, 12 (21.1%) were normotherapeutic, and 11 (19.3%) were subtherapeutic. EKG findings varied but most commonly described sinus node dysfunction with a variable degree of sinoatrial block with sinus bradycardia (54.39%) and sinus arrest (29.82%) predominating. Twelve patients (21.1%) required inotrope or vasopressor support. 10 (17.5%) of patient required temporary pacing while 7 (12.3%) required permanent pacemaker implantation. In the majority of cases no significant permanent sequelae were reported as 50 (87.7%) patients recovered, 2 (3.5%) patients had persistent sinus node dysfunction, and 2 (3.5%) patients expired as a result of acute lithium toxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion &amp;amp; conclusion<\/jats:title><jats:p>In this review we report the most up-to-date and comprehensive clinical compendium of lithium-associated sinus node dysfunction along with describing a novel treatment methodology to rapidly correct lithium-induced cardiac toxicity in a patient with long-standing bipolar disorder on chronic lithium treatment. We have reviewed the available literature and provide a comprehensive summary detailing symptomatology of presentation, treatments utilized, electrocardiographic findings and patient prognoses. We have concluded that under the presumptive conditions that transient sinus node dysfunction will resolve with elimination of toxic concentrations of lithium, temporary chronotropic support provided by theophylline administration would be preferable to more invasive measures such as hemodialysis, temporary pacing, or implantation of a permanent pacemaker.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1412376","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T04:58:17Z","timestamp":1724907497000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Oral theophylline corrects sinus node dysfunction in acute on chronic lithium toxicity: case report and systematic review of lithium-induced Sinus node dysfunction"],"prefix":"10.3389","volume":"11","author":[{"given":"J. Curran","family":"Henson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Morehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Hagood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niroshi","family":"Wijewardane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Paydak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"B1","first-page":"179","article-title":"Sinus node dysfunction","volume":"104","author":"Hawks","year":"2021","journal-title":"Am Fam Physician"},{"key":"B2","first-page":"1725","article-title":"Diagnosis and treatment of sick sinus syndrome","volume":"67","author":"Ad\u00e1n","year":"2003","journal-title":"Am Fam Physician"},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccep.2018.02.002","article-title":"Sick sinus syndrome","volume":"10","author":"De Ponti","year":"2018","journal-title":"Card Electrophysiol Clin"},{"key":"B4","first-page":"e382","article-title":"2018 ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm society","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"B5","first-page":"691","article-title":"Sick sinus syndrome: a review","volume":"87","author":"Semelka","year":"2013","journal-title":"Am Fam Physician"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1172\/JCI200318062","article-title":"Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A)","volume":"112","author":"Benson","year":"2003","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1113\/jphysiol.2003.039768","article-title":"Molecular basis of the effect of potassium on heterologously expressed pacemaker (HCN) channels","volume":"547","author":"Azene","year":"2003","journal-title":"J Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/hh1201.092095","article-title":"Sinoatrial nodal cell ryanodine receptor and na(+)-ca(2+) exchanger: molecular partners in pacemaker regulation","volume":"88","author":"Bogdanov","year":"2001","journal-title":"Circ Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S1050-1738(02)00162-7","article-title":"Cardiac HCN channels: structure, function, and modulation","volume":"12","author":"Biel","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0828-282X(07)70750-X","article-title":"Lithium-induced sinus node disease at therapeutic concentrations: linking lithium-induced blockade of sodium channels to impaired pacemaker activity","volume":"23","author":"Oudit","year":"2007","journal-title":"Can J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.31083\/j.rcm.2020.03.22","article-title":"Positive chronotropic effects of theophylline and cilostazol in patients with symptomatic sick sinus syndrome who have declined permanent pacing","volume":"21","author":"Jin","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/0735-1097(93)90246-W","article-title":"Effects of oral theophylline on sick sinus syndrome","volume":"21","author":"Saito","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/clinpract11020047","article-title":"Theophylline in treatment of COVID-19 induced Sinus bradycardia","volume":"11","author":"Sawalha","year":"2021","journal-title":"Clin Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.12968\/hmed.2010.71.4.47513","article-title":"Lithium toxicity: the importance of clinical signs","volume":"71","author":"Dunne","year":"2010","journal-title":"Br J Hosp Med Lond Engl"},{"key":"B16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/08998280.2008.11928407","article-title":"Effectiveness of normal saline diuresis in treating lithium overdose","volume":"21","author":"Boltan","year":"2008","journal-title":"Proc Bayl Univ Med Cent"},{"key":"B17","volume-title":"Lithium Toxicity","author":"Hedya","year":"2024"},{"key":"B18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/BF03259929","article-title":"Clinical features and management of lithium poisoning","volume":"3","author":"Amdisen","year":"1988","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.ijcard.2013.03.144","article-title":"Oral theophylline as temporizing treatment of neck mass induced carotid sinus syncope","volume":"167","author":"Vallurupalli","year":"2013","journal-title":"Int J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0002-9343(75)90365-4","article-title":"Symptomatic sinus node abnormalities following lithium carbonate therapy","volume":"59","author":"Wellens","year":"1975","journal-title":"Am J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0025-6196(11)63701-4","article-title":"Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice","volume":"73","author":"Vassallo","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/01.CIR.96.1.260","article-title":"Effects of permanent pacemaker and oral theophylline in sick Sinus syndrome","volume":"96","author":"Alboni","year":"1997","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/01.CIR.67.1.116","article-title":"Theophylline for the treatment of symptomatic sinus node dysfunction: efficacy and possible predictors of response","volume":"67","author":"Benditt","year":"1983","journal-title":"Circulation"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1412376\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T04:58:22Z","timestamp":1724907502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1412376\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2024.1412376"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1412376","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"article-number":"1412376"}}